Survival of a patient with five recurrences of retroperitoneal liposarcoma over a period of 13 years: A case report and review

Oncol Lett. 2023 Jul 12;26(3):367. doi: 10.3892/ol.2023.13953. eCollection 2023 Sep.

Abstract

Retroperitoneal liposarcoma (RPLS) is a rare tumor that occurs in the retroperitoneal region and accounts for ~0.2% of all malignant tumor incidence. The present study describes the treatment of a surviving patient with RPLS that recurred five times in 13 years. This case has a long survival time and numerous relapses, which is a rare occurrence. The 40-year-old female patient was admitted to Shaoxing Second Hospital (Shaoxing, China) with an abdominal mass. Abdominal computed tomography (CT) scan revealed multiple liposarcoma recurrences in the abdominal, pelvic and retroperitoneal areas. As the diagnosis of RPLS was the fifth recurrence, cytoreductive surgery was performed and post-operative pathology suggested mixed liposarcoma. The patient underwent six cycles of doxorubicin and ifosfamide regimen chemotherapy and targeted therapy with anlotinib following surgery; no evidence of disease progression was found on abdominal CT scan during follow-up. The present study also reviewed the literature in terms of the clinical diagnosis, treatment, pathological characteristics and similar cases of liposarcoma with the aim of improving diagnosis and treatment.

Keywords: case report; chemotherapy; liposarcoma; pathology; recurrence; retroperitoneal liposarcoma; tumor.

Publication types

  • Case Reports

Grants and funding

Funding: No funding was received.